يعرض 1 - 20 نتائج من 135 نتيجة بحث عن '"Coward, Eivind"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
    Academic Journal
  5. 5
  6. 6
  7. 7
    Academic Journal
  8. 8
  9. 9
    Academic Journal

    المصدر: Misund , K , Hofste op Bruinink , D , Coward , E , Hoogenboezem , R M , Rustad , E H , Sanders , M A , Rye , M , Sponaas , A-M , van der Holt , B , Zweegman , S , Hovig , E , Meza-Zepeda , L A , Sundan , A , Myklebost , O , Sonneveld , P & Waage , A 2022 , ' Clonal evolution after treatment pressure in multiple myeloma : heterogenous genomic aberrations and transcriptomic convergence ' , Leukemia , vol. 36 , no. 7 , ....

  10. 10
    Academic Journal

    المصدر: 2234-943X.

    Relation: EC/H2020/801133; SKGJ/SKGJ-MED-019; NFR/294916; NFR/322898; HSØ/2015031; Giliberto, Mariaserena Miranda Santana, Leonardo Holien, Toril Misund, Kristine Nakken, Sigve Vodak, Daniel Hovig, Eivind Meza, Leonardo Zepeda Coward, Eivind Waage, Anders Tasken, Kjetil Skånland, Sigrid S . Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines. Frontiers in Oncology. 2022, 12:1040730, 1-14; http://hdl.handle.net/10852/100136; 2097531; info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Oncology&rft.volume=12:1040730&rft.spage=1&rft.date=2022; Frontiers in Oncology; 12; https://doi.org/10.3389/fonc.2022.1040730

  11. 11
  12. 12
    Academic Journal
  13. 13
  14. 14
    Academic Journal
  15. 15
    Electronic Resource

    المصدر: Brumpton , B M , Graham , S , Surakka , I , Skogholt , A H , Løset , M , Fritsche , L G , Wolford , B , Zhou , W , Nielsen , J B , Holmen , O L , Gabrielsen , M E , Thomas , L , Bhatta , L , Rasheed , H , Zhang , H , Kang , H M , Hornsby , W , Moksnes , M R , Coward , E , Melbye , M , Giskeødegård , G F , Fenstad , J , Krokstad , S , Næss , M , Langhammer , A , Boehnke , M , Abecasis , G R , Åsvold , B O , Hveem , K & Willer , C J 2022 , ' The HUNT study : A population-based cohort for genetic research ' , Cell Genomics , vol. 2 , no. 10 , 100193 .

  16. 16
    Report
  17. 17
    Report
  18. 18
    Academic Journal

    المصدر: Giliberto, Mariaserena Miranda Santana, Leonardo Holien, Toril Misund, Kristine Nakken, Sigve Vodak, Daniel Hovig, Eivind Meza, Leonardo Zepeda Coward, Eivind Waage, Anders Tasken, Kjetil Skånland, Sigrid S . Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines. Frontiers in Oncology. 2022, 12:1040730, 1-14
    Frontiers in Oncology

    Relation: EC/H2020/801133

  19. 19
    Academic Journal

    المصدر: Misund, Kristine Hofste op Bruinink, Davine Coward, Eivind Hoogenboezem, Remco M. Rustad, Even Holth Sanders, Mathijs A. Rye, Morten Beck Sponaas, Anne-Marit van der Holt, Bronno Zweegman, Sonja Hovig, Eivind Meza, Leonardo Zepeda Sundan, Anders Myklebost, Ola Sonneveld, Pieter Waage, Anders . Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia. 2022, 36(7), 1887-1897
    Leukemia

  20. 20
    Academic Journal

    المصدر: 2044-5385.

    Relation: http://urn.nb.no/URN:NBN:no-50365; Rustad, Even Holth Dai, Hong Yan Hov, Håkon Coward, Eivind Beisvag, Vidar Myklebost, Ola Hovig, Eivind Nakken, Sigve Vodak, Daniel Meza-Zepeda, Leonardo A. Sandvik, Arne Kristian Wader, Karin Fahl Misund, Kristine Sundan, Anders Aarset, Harald Waage, Anders . BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis. Blood Cancer Journal. 2015; http://hdl.handle.net/10852/46173; 1236661; info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Blood Cancer Journal&rft.volume=&rft.spage=&rft.date=2015; Blood Cancer Journal; http://dx.doi.org/10.1038/bcj.2015.24; URN:NBN:no-50365; Fulltext https://www.duo.uio.no/bitstream/handle/10852/46173/2/bcj201524a.pdf